DEVLOG #6 Hey everyone!This is probably the last devlog for DOSEFIELD, at least for a while. It’s been an incredible journey—from the first rough prototype to something I’m genuinely proud to share. Thank you to everyone who followed along, tested the project, gave feedback, or simply read these updates. It really meant a lot.v2.3 is the “show your work” release. Nothing changed in the physics—and that’s exactly the point.The biggest addition is a new Methods page that renders the repository’s own METHODS.md and limitations table directly. That means anyone reading the website sees the exact same equations, assumptions, and all 12 limitations that exist in the source code. If the website and the repository ever disagree, the repository is the source of truth.Every page now also includes a provenance footer that’s generated automatically during the build. Instead of typing in a version number by hand, the site runs git rev-parse and the full test suite, then stamps something like:commit e22ef18 · 111/111 tests · verified 2026-07-18The build will actually fail if the tests don’t pass, so it’s impossible to accidentally display a “green” verification badge on a broken build.I also improved chart exports. Figures now render at 3200 px, and each exported chart includes its full configuration in the caption. That makes it much easier to trace a plot back to the exact settings that produced it, whether it’s used in a poster, report, or presentation.One thing I want to be completely clear about: this verification is about the software, not the physics. Passing 111 tests means the implementation behaves as expected according to those tests—it doesn’t prove the scientific model is perfect. The current validation remains the same: about 2× agreement with MSL/RAD, and the 0.67× absorbed-dose gap is still there, clearly documented.That’s exactly what this release is about: transparency over hype, reproducibility over screenshots, and being honest about what the model can—and can’t—do.Thanks for following this project. ❤️
Comments 0
No comments yet. Be the first!
Sign in to join the conversation.